ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Dimethyl fumarate ameliorates lipopolysaccharide-induced acute lung injury by inhibiting NLRP3 inflammasome-mediated pyroptosis through enhancing Nrf2 signaling

Li, Huayu; Li, Mengyan; Dong, Chao; Liu, Bing*广东药学院; 1
2022-6-28DOI: 10.1093/toxres/tfac020
5被引21阅读
引用收藏
分享

摘要

Background Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) are clinically severe respiratory disorders, and there are currently no Food and Drug Administration-approved drug therapies. It is of great interest to us that dimethyl fumarate (DMF) has been shown to have anti-inflammatory effects. The aim of this study was to investigate whether DMF could alleviate lipopolysaccharide(LPS)-induced ALI, and to explore its mechanism of action. Materials and methods We established a mice model of ALI with intratracheal instillation of LPS and intraperitoneal injection of DMF to treat ALI. The pathological damage and inflammatory response of lung tissues were observed by hematoxylin and eosin (H&E) staining, ELISA assay and western blot. ATP plus LPS was used for the establishment of ALI in vitro model, the therapeutic effects of DMF was explored by ELISA assay, RT-qPCR, western blot, and flow cytometry, and the therapeutic mechanisms of DMF was explored by administration of Brusatol (BT), a nuclear factor erythroid-2-related factor 2 (Nrf2) inhibitor. Results We found that intraperitoneal injection of DMF significantly reduced LPS-induced the pulmonary injury, pulmonary edema, and infiltration of inflammatory mediators. In LPS-induced ALI, NLRP3 inflammasome-mediated pyroptosis was markedly activated, followed by cleavage of caspase-1 and GSDMD. DMF inhibited the activation of the NLRP3 inflammasome and pyroptosis in both lung of ALI mice and ATP plus LPS-induced BEAS-2B cells. Mechanistically, DMF enhanced expressions of Nrf2, leading to inactivation of NLRP3 inflammasome and reduced pyroptosis in vivo and in vitro. Conversely, BT reduced the inhibitory effects of DMF on NLRP3 inflammasome and pyroptosis, and consequently blocked the improvement roles of DMF on ALI. Conclusions DMF could improve LPS-induced ALI via inhibiting NLRP3 inflammasome and pyroptosis, and that these effects were mediated by triggering Nrf2 expression, suggesting a therapeutic potential of DMF as an anti-inflammatory agent for ALI/ARDS treatment.

学科与关键词

关键词
acute lung injurydimethyl fumarateNLRP3 inflammasomepyroptosisNrf2
相关
加载中…
  • Inhibition of endotoxin-induced acute lung injury in rats by bone marrow-derived mesenchymal stem cells: Role of Nrf2/HO-1 signal axis in inhibition of NLRP3 activation
    Lei, Lihua; Guo, Yiqing; Lin, Jun; Lin, Xiaohua; He, Shiling; Qin, Zaisheng*; Lin, Qun*Biochemical and Biophysical Research Communications, 2021, 551: 7-13.被引 11
  • Dexmedetomidine Attenuates LPS-Induced Acute Lung Injury in Rats by Activating the Nrf2/ARE Pathway
    Qiu, Yuandong; Tang, Zhiwei*Journal of Healthcare Engineering, 2022, 2022: 4185195.被引 2
  • 5-Methoxyflavone alleviates LPS-mediated lung injury by promoting Nrf2-mediated the suppression of NOX4/TLR4 axis in bronchial epithelial cells and M1 polarization in macrophages
    Liang, Panqiao; Wang, Linxin; Yang, Sushan; Pan, Xiping; Li, Jiashun; Zhang, Yuehan; Liang, Yueyun; Li, Jing; Zhou, Beixian*Journal of Inflammation-London, 2022, 19(1): 24.被引 3
查看全部 →

发表信息

论文状态
公开发表
发表日期
2022-06-28
卷期
第 11 卷, 第 3 期
页码
437-450
DOI
10.1093/toxres/tfac020
语言
ENGLISH
期刊等级
3区
成果收录
SCIE
资助标注
National Key Clinical Specialty Construction Project (Clinical Pharmacy); High Level Clinical Key Specialty (Clinical Pharmacy) in Guangdong Province

作者

  • L

    Li, Huayu (第一作者)

    guangdong pharmaceut univ

  • L

    Li, Mengyan

    guangdong pharmaceut univ

查看全部 4 位作者收起作者
  • D

    Dong, Chao

    guangdong pharmaceut univ

  • L

    Liu, Bing (通讯)

    1 · guangdong pharmaceut univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417